{"schema_version":"secwatch.filing_event.v1","accession":"0000096943-26-000031","form_type":"8-K","ticker":"TFX","cik":"0000096943","company_name":"TELEFLEX INC","filed_at":"2026-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.105226+00:00","generated_at":"2026-05-15T11:18:23.840075+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Teleflex updates on OEM and Acute Care divestitures; FTC Second Request for urology deal","bullets":["OEM HSR waiting period expired March 13, 2026; closing anticipated in Q3 2026.","Acute Care and Urology deal received FTC Second Request on March 11, extending HSR review.","Company and Intersurgical cooperating with FTC; close expected in H2 2026.","Both transactions, announced Dec 9, 2025, are separate and subject to other conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0000096943-26-000031","json":"https://secwatch.observer/filing/0000096943-26-000031.json","markdown":"https://secwatch.observer/filing/0000096943-26-000031.md","text":"https://secwatch.observer/filing/0000096943-26-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/96943/000009694326000031/0000096943-26-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/96943/000009694326000031/tfx-20260311.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T11:18:23.840075+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}